The 63 rating InvestorsObserver gives to Biomarin Pharmaceutical Inc (BMRN) stock puts it near the top of the Biotechnology industry. In addition to scoring higher than 78 percent of stocks in the Biotechnology industry, BMRN’s 63 overall rating means the stock scores better than 63 percent of all stocks.
BMRN has an Overall Score of 63. Find out what this means to you and get the rest of the rankings on BMRN!
Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 63 means the stock is more attractive than 63 percent of stocks.
This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.
What's Happening With Biomarin Pharmaceutical Inc Stock Today?
Biomarin Pharmaceutical Inc (BMRN) stock is higher by 1.64% while the S&P 500 has fallen -1.66% as of 3:47 PM on Monday, Nov 28. BMRN has gained $1.59 from the previous closing price of $96.92 on volume of 1,635,333 shares. Over the past year the S&P 500 is lower by -14.95% while BMRN has gained 12.71%. BMRN earned $0.42 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 236.65.
Click Here to get the full Stock Report for Biomarin Pharmaceutical Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
